Table 3. Mean fluorescence intensity (MFI) and stain index (SI) values obtained for different sets of reagents evaluated in normal PB samples (n=5).
Marker | PacB | HV450 | P-valuea | |||||
---|---|---|---|---|---|---|---|---|
CD2 | Clone (manufacturer) | TS1/8 (BioLegend) | S5.2 (BD B) | |||||
MFI±s.d. of CD2+ T and NK-cells | 5741±755.7 | 8259±1792.8 | 0.02 | |||||
SIc | 37.0 | 41.4 | ||||||
CD3 | Clone (manufacturer) | UCHT1 (BD Ph) | UCHT1 (BD B) | |
|
|
|
|
MFI±s.d. of T-cells | 15 774±1503.7 | 17 246±814.2 | 0.08 |
APCCy7 |
AF700 |
APCH7 |
P-valueb |
|
SId | 117.2 | 130.5 | ||||||
CD4 | Clone (manufacturer) | RPA-T4 (BD Ph) | RPA-T4 (BD B) | RPA-T4 (BD B) | RPA-T4 (BD B) | RPA-T4 (BD B) | ||
MFI±s.d. of CD4+ T-cells | 9474±710.2 | 9195±408.2 | 0.46 | 13 596±686.5 | 4307±174.1 | 9910±414.3 | <0.001 | |
SIe | 61.8 | 66.6 | 42.6 | 41.4 | 35.0 | |||
CD20 | Clone (manufacturer) | 2H7 (eBiosciences) | L27 (BD B) | |
|
|
|
|
MFI±s.d. of B-cells | 30 073±3783.5 | 38 152±2857.4 | 0.005 |
PacO |
AmCyan |
HV500 |
P-valueb |
|
SIf | 219.61 | 222.8 | ||||||
CD45 | Clone (manufacturer) | T29/33 (Dako) | HI30 (BD B) | HI30 (Invitrogen) | 2D1 (BD B) | HI30 (BD B) | ||
MFI±s.d. of lymphocytes | 30 742±824.8 | 53 709±2062.2 | <0.001 | 5521±150.6 | 30 681±2838.3 | 19 157±686.3 | <0.001 | |
SIg | 3.9 | 5.2 | 3.8 | 4.8 | 3.8 | |||
HLADR | Clone (manufacturer) | L243 (BioLegend) | L243 (BD B) | |||||
MFI±s.d. of monocytes | 11 509±1721.4 | 16 874±1934.3 | 0.002 | |||||
SIh | 47.7 | 64.8 |
Abbreviations: AF700, alexa fluor 700; AmCyan, Anemonia Majano cyan fluorescent protein; APCCy7, allophycocyanin–cyanin7; APCH7, allophycocyanin–hilite7; BD Ph, BD Pharmingen; BD B, BD Biosciences; HV450, Horizon V450; HV500, Horizon V500; PacB, pacific blue; PacO, pacific orange.
Paired Student's T-test.
P<0.001 for the following comparisons: APCH7 versus AF700, AF700 versus APCCy7, APCCy7 versus APCH7, PacO versus AmCyan, PacO versus HV500 and AmCyan versus HV500 (paired Student's T-test).
Positive reference population (PRP): CD2+ T- and NK-cells and negative reference population (NRP), CD2− lymphocytes.
PRP, T-cells; NRP, B- and NK-cells.
PRP, CD4+ T-cells; NRP, CD4− T-cells.
PRP, B-cells; NRP, T- and NK-cells.
PRP, lymphocytes; NRP, neutrophils.
PRP, monocytes; NRP, lymphocytes.